Düsseldorf team uncovers common cause of thrombosis and aneurysms
Researchers at the Department of Vascular and Endovascular Surgery at the University Hospital Düsseldorf and Heinrich Heine University have shown that the interaction between platelets and erythrocytes via the proteins CD36 and TSP-1 promotes both thrombosis and...
NRAHF calls for funding for heart registries
The National Register for Congenital Heart Defects takes stock of the petition "Every heart counts" and appeals to politicians to create reliable funding for medical registers. Although the draft of the Medical Register Act offers a framework, it fails to secure...
H3N2: Facts instead of panic – The current flu situation 2025/2026 explained in an understandable way
The 2025/2026 flu season is in full swing, and in many countries, including the US and Europe, the H3N2 influenza A subtype dominates, especially the new genetic variant Subclade K. Media reports sometimes speak of a "new dangerous variant" or even "super flu", which...
Funding for new diagnostic procedure for collagenosis
The PREDICT-CTD project will receive 2.7 million euros from the zukunft.niedersachsen programme. Over a period of five years, a team from TWINCORE, Helmholtz Centre for Infection Research and Hannover Medical School led by Theresa Graalmann and Yannic Bartsch has been...
KKNMS criticizes abuses in ASV multiple sclerosis
In a statement, the Multiple Sclerosis Competence Network has denounced administrative and content-related deficits in outpatient specialist care for MS patients. The ASV-MS, introduced in 2024, does not meet its goals of better coordination and quality improvement,...
IQWiG publishes updated Methods 8.0 and new minimum retention number methodology
The Institute for Quality and Efficiency in Health Care has published version 8.0 of its General Methods, which form the basis for assessments in statutory health insurance. The revision takes into account comments from a hearing at the end of February 2025, with...
UKHD receives approval for its own CAR-T cell product against CLL
Heidelberg University Hospital is the first academic institution in Germany to receive a hospital exemption from the Paul-Ehrlich-Institut for the production and use of the CAR-T cell product Heidagen-lecleucel. The patient's own immune cell preparation is directed...
AFI launches call for dementia funding 2026
The Alzheimer Research Initiative e.V. has opened its annual call for funding for research into Alzheimer's and related dementias. Researchers can submit applications until 30 January 2026 to fund projects in basic research and applied science. The initiative aims to...
Research team optimizes light-sheet microscopy for precise 3D imaging
An interdisciplinary team from the University of Göttingen, the University Medical Center Göttingen and the University of Lübeck has developed an innovative platform for light sheet fluorescence microscopes that revolutionizes the imaging of large tissue samples. The...
Mouse model: NU-9 stops Alzheimer’s development before symptoms
Researchers at Northwestern University have demonstrated further progress in early intervention against Alzheimer's with the experimental drug NU-9. In a new study, they identified a previously unknown, highly toxic subtype of amyloid beta oligomers that triggers...
